NCT01418339 - Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder | Biotech Hunter

Enrollment

135

Participants

Timeline

Start Date

July 27, 2011

Primary Completion Date

November 6, 2013

Study Completion Date

November 6, 2013

Conditions

Tourette's Disorder

Interventions

DRUG

Aripiprazole

Aripiprazole tablet administered orally once a week.

DRUG

Placebo

Aripiprazole-matching placebo tablet administered orally once a week.

Trial Locations (39)

100

Taipei

114

Taipei

1021

Budapest

6725

Szeged

10312

Staten Island

19139

Philadelphia

32763

Orange City

33012

Hialeah

33701

St. Petersburg

34000

Durango

37000

León

40447

Taichung

44012

Avon Lake

44106

Cleveland

44130

Middleburg Heights

48302

Bloomfield Hills

50006

Changhua

64710

Monterrey

66211

Overland Park

70114

New Orleans

72205

Little Rock

75230

Dallas

78229

San Antonio

78258

San Antonio

83301

Kaohsiung City

84107

Salt Lake City

92595

Wildomar

92701

Santa Ana

95815

Sacramento

98011

Bothell

460727

Gyeonggi-do

V1Y 1Z9

Kelowna

M5B 1T8

Toronto

L1N 8M7

Whitby

626-770

Gyeongsang

400-711

Incheon

110-769

Seoul

138-736

Seoul

143-729

Seoul

All Listed Sponsors

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY